WEDXF Westaim Corp featured news, full reports, and detailed charts
Westaim Corp (WEDXF/WEDXF.PK) Wrap Up:
The Westaim Corporation, through its subsidiary, Nucryst Pharmaceuticals Corp., engages in the development, manufacture, and commercialization of wound care products and pharmaceutical products based on noble metal nanocrystalline technology. It offers Acticoat Burn Dressings and Acticoat 7 Dressings that fight infection and inflammation for the treatment of burns and chronic wounds. The Westaim Corporation also develops a pharmaceutical product for the treatment of gastrointestinal conditions, as well as NPI 32101, a topical cream used as a medical device for the treatment of dermatological conditions. The company was founded in 1996 and is headquartered in Calgary, Canada.Westaim Corp (WEDXF:OTC)
|
Market Cap
39.4M
|
Total Revenue
24.6M
|
|
|
EBITDA
4.3M
|
DILUTED EPS TTM
-0.05
|
|
|
P/E
--
|
P/S
2.0x
|
|
|
Return On Asset
-5.50
|
Return On Equity
-10.12
|
|
| K = Thousands M = Millions B = Billions | ||
WEDXF Top Compensated Officers
Executives, Board Directors
Key developments for Westaim Corp (WEDXF)
Westaim Corp. reported consolidated earnings results for the third quarter and nine months ended September 30, 2009. For the quarter, the company reported loss from continuing operations of $18,000 or $0.00 per basic and diluted share against $1,851,000 or $0.02 per basic and diluted share for the same period a year ago. Net loss was $175,000 or $0.00 per basic and diluted share on revenue of $6,672,000 against net loss of $3,122,000 or $0.03 per basic and diluted share on revenue of $5,466,000 for the same period a year ago. For the nine months, the company reported loss from continuing operations of $3,382,000 or $0.04 per basic and diluted share against $511,000 or $0.01 per basic and diluted share for the same period a year ago. Net loss was $4,144,000 or $0.04 per basic and diluted share on revenue of $17,644,000 against net loss of $12,981,000 or $0.14 per basic and diluted share on revenue of $15,428,000 for the same period a year ago.
Westaim Corp. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2009. For the quarter, the company reported operating income of $293,000 and comprehensive loss of $442,000 compared to the operating loss of $1,747,000 and comprehensive loss of $2,620,000 for the same period a year ago. The company reported cash provided by operating activities of $717,000 compared to the cash used in operating activities of $1,239,000 for the same period a year ago. The company reported capital expenditures of $84,000 compared to the capital expenditures of $191,000 for the same period a year ago. For nine months, the company reported operating loss of $3,869,000 and comprehensive loss of $4,214,000 compared to the operating loss of $8,851,000 and comprehensive loss of $12,103,000 for the same period a year ago. The company reported cash used in operating activities of $3,258,000 compared to the cash provided by operating activities of $2,209,000 for the same period a year ago. The company reported capital expenditures of $369,000 compared to the capital expenditures of $1,077,000 for the same period a year ago.
Westaim Corp. reported consolidated unaudited earnings results for the second quarter and six months ended June 30, 2009. For the quarter, the company reported loss from continuing operations of $1,025,000 or $0.01 per basic and diluted share against $1,887,000 or $0.02 per basic and diluted share for the same period a year ago. Net loss was $1,288,000 or $0.01 per basic and diluted share on revenue of $5,798,000 against net loss of $3,002,000 or $0.03 per basic and diluted share n revenue of $4,754,000 for the same period a year ago. For the six months, the company reported loss from continuing operations of $3,364,000 or $0.04 per basic and diluted share against income of $1,340,000 or $0.01 per basic and diluted share for the same period a year ago. Net loss was $3,969,000 or $0.04 per basic and diluted share on revenue of $10,972,000 against net loss of $9,859,000 or $0.10 per basic and diluted share n revenue of $9,962,000 for the same period a year ago.
WEDXF Competitors
| Company | Last | Change |
| 3M Company | $76.64 USD | -0.61 |
| Kinetic Concepts Inc | $33.36 USD | -0.32 |
| Paul Hartmann | €145.00 EUR | 0.00 |
| Uni-Pixel Inc | $0.55 USD | -0.08 |
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | WEDXF | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 2.0x |
|
| Price/Book | 1.0x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | NM | Not Meaningful |
|
WEDXF |
||
WEDXF transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
